CA1227427A - Agent therapeutique utilise dans le traitement du cancer - Google Patents

Agent therapeutique utilise dans le traitement du cancer

Info

Publication number
CA1227427A
CA1227427A CA000461144A CA461144A CA1227427A CA 1227427 A CA1227427 A CA 1227427A CA 000461144 A CA000461144 A CA 000461144A CA 461144 A CA461144 A CA 461144A CA 1227427 A CA1227427 A CA 1227427A
Authority
CA
Canada
Prior art keywords
tumor
group
cells
polysulfate
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000461144A
Other languages
English (en)
Inventor
Albert Landsberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA000461144A priority Critical patent/CA1227427A/fr
Application granted granted Critical
Publication of CA1227427A publication Critical patent/CA1227427A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000461144A 1984-08-16 1984-08-16 Agent therapeutique utilise dans le traitement du cancer Expired CA1227427A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000461144A CA1227427A (fr) 1984-08-16 1984-08-16 Agent therapeutique utilise dans le traitement du cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000461144A CA1227427A (fr) 1984-08-16 1984-08-16 Agent therapeutique utilise dans le traitement du cancer

Publications (1)

Publication Number Publication Date
CA1227427A true CA1227427A (fr) 1987-09-29

Family

ID=4128538

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000461144A Expired CA1227427A (fr) 1984-08-16 1984-08-16 Agent therapeutique utilise dans le traitement du cancer

Country Status (1)

Country Link
CA (1) CA1227427A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041730A1 (fr) * 1999-01-13 2000-07-20 Meditech Research Limited Composition visant a accroitre l'efficacite de medicaments et methodes afferentes
US8287894B2 (en) 2000-07-14 2012-10-16 Alchemia Oncology Pty Limited Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
US8623354B2 (en) 2005-09-07 2014-01-07 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
US8937052B2 (en) 2005-07-27 2015-01-20 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041730A1 (fr) * 1999-01-13 2000-07-20 Meditech Research Limited Composition visant a accroitre l'efficacite de medicaments et methodes afferentes
US8741970B2 (en) 1999-01-13 2014-06-03 Alchemia Oncology Pty Limited Composition and method for the enhancement of the efficacy of drugs
US8287894B2 (en) 2000-07-14 2012-10-16 Alchemia Oncology Pty Limited Hyaluronan as a drug pre-sensitizer and chemo-sensitizer in the treatment of disease
US8388993B2 (en) 2000-07-14 2013-03-05 Alchemia Oncology Pty Limited Hyaluronan-chemotherapeutic agent formulations for the treatment of colon cancer
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US8937052B2 (en) 2005-07-27 2015-01-20 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
US8623354B2 (en) 2005-09-07 2014-01-07 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

Similar Documents

Publication Publication Date Title
Taylor et al. Protamine is an inhibitor of angiogenesis
US4710493A (en) Therapeutic agent for the use in cancer treatment
US4801619A (en) Hyaluronic acid preparation to be used for treating inflammations of skeletal joints
Bachur et al. Adriamycin and daunorubicin disposition in the rabbit
AU624331B2 (en) A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
DE69907664T2 (de) Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung
DE69011703T2 (de) Therapeutisches Arzneimittel gegen Thrombose und Verfahren zur Herstellung.
JPH10130162A (ja) ヒアルロン酸分解阻害剤、ヒアルロン酸異常分解疾患治療剤および化粧料
HU220784B1 (hu) Antiangiogén aktivitással és tumorregressziós hatással rendelkező cápaporcextraktum és eljárás előállítására
CZ245297A3 (cs) Extrakty žraločí chrupavky, způsob jejich výroby a jejich použití
EP0363491B1 (fr) Preparation bacterienne pour prophylaxie et traitement de processus inflammatoires et d'affections allergiques
CA1227427A (fr) Agent therapeutique utilise dans le traitement du cancer
EP2051719B1 (fr) Préparation à base de collagène marin pour inhiber la protéinase
Aqsa et al. Efficacy of Aloe vera cream for healing diabetic foot ulcers
KR910000146A (ko) 동결- 건조된 조성물 및 그 제조 방법
Wolinsky Chemotherapy and pathology of experimental photochromogenic mycobacterial infections
US7132412B2 (en) Treatment of skin diseases using a pharmaceutical preparation in colloidal form
WO1991003226A2 (fr) Compositions pharmaceutiques contenant des polymeres aromatiques et procedes therapeutiques les employant
CN1067246C (zh) N－乙酰－d－氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用
US6156349A (en) Method of treating HIV infection with suppository containing mammalian liver extract
PT653939E (pt) Utilizacao de um veneno de himenoptero para o fabrico de um medicamento para o tratamento de infeccoes por virus de adn
Schapira et al. Severe myalgia in familial Mediterranean fever: clinical and ultrastructural aspects.
RU2248212C2 (ru) Препарат для лечения бактериального вагиноза, способ его получения и способ лечения бактериального вагиноза
RU2110272C1 (ru) Средство для лечения термических поражений кожи, трофических язв, пролежней и длительно незаживающих ран
KR20160122052A (ko) 피뿌리풀 추출물 또는 그의 분획물을 포함하는 상처를 치료하기 위한 조성물 및 개체의 상처를 치료하는 방법

Legal Events

Date Code Title Description
MKEX Expiry